Eloxx Pharmaceuticals Highlights Recent Alport Syndrome Natural History Data Presented at 60th ERA Congress

10 months ago

Data from RaDaR natural history study indicates that Alport syndrome patients with autosomal recessive COL4A4 mutations have severest disease, with…

Earth Science Tech, Inc Shares a Letter from the CEO on Recently Filed March 31, 2023, YE Report

10 months ago

“You don’t have to be great to start, but you do have to start to be great!” Miami, FL, June…

Dyadic Announced an MoU with Bangladesh’s State-Owned Pharmaceutical Company to Facilitate Biopharmaceutical Research and Biomanufacturing Capacity

10 months ago

JUPITER, Fla. and DHAKA, Bangladesh, June 21, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the…

HMNC Brain Health to Participate in the Psychedelic Science Conference 2023 and the H.C. Wainwright & Co. 4th Annual Neuropsychiatry Conference

10 months ago

MUNICH, Germany, June 21, 2023 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a global clinical-stage biopharmaceutical company,…

Tumult Labs Helps Wikimedia Foundation Ensure Privacy of Detailed Data Usage Metrics

10 months ago

Differential Privacy Pioneer Supports Need to Share Granular, Country-level Data Publicly for the First Time without Compromising PrivacyDURHAM, N.C., June…

Women In Bio Connecticut hosts Panel at Yale Innovation Summit

10 months ago

WIB-CT How to Build a Better Board Erika Smith (left to right), CEO ReNetX, moderated WIB-CT’s How to Build a…

SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023

10 months ago

SAB highlights results from GLP toxicology study confirming SAB-142's mechanism of action at the 23rd Federation of Clinical Immunology Societies…

NewRegen Experiences Significant Growth in the Health and Wellness Space

10 months ago

ATLANTA, GA, June 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – NewRegen (OTC:NREG), a leading comprehensive wellness services company, today…

Veru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants

10 months ago

Research grants from U.S. Department of Defense (DoD) and National Cancer Institute’s Research Project Grant (NCI R01) awarded to UTHSC…

CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath

10 months ago

BERKELEY HEIGHTS, N.J., June 21, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…